Health care startups in Switzerland
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Laza Medical | Pfaffikon | Series B | $160.0M | 2026-11-04 |
| Rivia | Zürich | Series A | $15.0M | 2026-03-18 |
| Vaderis Therapeutics | Basel | Series B | $152.0M | 2026-08-11 |
| Windward Bio | Basel | Series B | $165.0M | 2026-05-04 |
| Avea Life | Zug | Angel | $2.2M | 2026-10-20 |
| Alithea Genomics | Lausanne | Seed | $3.8M | 2026-03-04 |
| GlycoEra | Wädenswil | Series B | $130.0M | 2025-05-27 |
| Cutiss | Zürich | Series C | $38.8M | 2025-09-10 |
8 rows of the CSV in 5 of its 18 columns.
- The 353 health care startups in Switzerland have raised $6.1B in total.
- 44 of them closed their most recent round in the last 12 months, $1.2B combined.
- The largest of those rounds is Oviva's $233.7M Series D, dated January 2026.
- The most recent is Vale Biolabs' $183K seed round on 9 November 2026.
- Venture Kick is an investor in 50 of them, more than any other fund.
- Biotech is the most common other sector, with 171 companies (48%).
- 31% were founded in 2020 or later; the median founding year is 2017.
- The most common team size is 1 to 10 employees (50% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
30 of 353| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Laza Medical | Laza Medical produces AI-powered robotic imaging systems for cardiovascular treatments. | Artificial intelligence | Pfaffikon | Series B | $160.0M | 2026-11-04 | $196.0M | Page One Ventures, Unorthodox Ventures, The Capital Partnership | 1 to 10 | 2020 |
| Avea Life | Avea Life formulates science-based longevity supplements in Switzerland. | Health care | Zug | Angel | $2.2M | 2026-10-20 | $7.6M | Maximon | 1 to 10 | 2021 |
| NovaGo Therapeutics | NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke. | Biotech | Schlieren | Series B | $29.7M | 2026-08-31 | $39.7M | Kinled Holding, Pureos Bioventures | 1 to 10 | 2015 |
| Bewelab SA | Bewelab SA uses neuroscience-based digital interventions to reduce cravings at the neural level. | Health care | Fribourg | Seed | $2.5M | 2026-08-19 | $5.5M | Future of Health Grant, Fribourg Innovation | 1 to 10 | 2021 |
| Vaderis Therapeutics | Vaderis Therapeutics develops targeted therapies for rare vascular diseases in clinical trials. | Biotech | Basel | Series B | $152.0M | 2026-08-11 | $170.6M | Medicxi | 11 to 50 | 2019 |
| Carewell | Carewell connects caregivers with flexible work opportunities through a marketplace platform. | Health care | Pully | Seed | $1.9M | 2026-07-03 | $2.4M | Foundation for Innovation and Technology (FIT) | 1 to 10 | 2024 |
| Windward Bio | Windward Bio develops monoclonal antibodies for advanced immunological diseases. | Biotech | Basel | Series B | $165.0M | 2026-05-04 | $365.0M | Qiming Venture Partners, OrbiMed, Novo Holdings +2 | 11 to 50 | 2024 |
| Rivia | Rivia provides an operating system that aims to improve clinical trial outcomes. | Artificial intelligence | Zürich | Series A | $15.0M | 2026-03-18 | $18.2M | Speedinvest, Nina Capital, Amino Collective | 1 to 10 | 2022 |
| Alithea Genomics | Alithea Genomics develops molecular biology tools and sequencing solutions for large-scale gene expression analysis. | Biotech | Lausanne | Seed | $3.8M | 2026-03-04 | $9.9M | Foundation for Innovation and Technology (FIT), TechU Ventures, Eurostars +1 | 11 to 50 | 2020 |
| ORamaVR | ORamaVR develops extended reality software that speeds up computational medical applications. | Education | Geneva | Seed | $4.5M | 2026-01-27 | $5.9M | European Commission, Innosuisse, FONGIT +1 | 11 to 50 | 2016 |
| Leman Biotech | Leman Biotech develops cancer immunotherapies as a biotech company. | Biotech | Lausanne | Series A | $28.8M | 2026-01-26 | $46.8M | Tiantu Capital, Fuho Capital | 11 to 50 | 2021 |
| FluoSphera | FluoSphera develops drugs. | Biotech | Geneva | Seed | $1.4M | 2026-01-12 | $3.9M | SOSV, SOSV SF & NY (Fka IndieBio), FONGIT Innovation Fund +2 | 1 to 10 | 2021 |
| Genknowme | Genknowme is a precision health company advancing epigenetics to support personalized and preventive care. | Biotech | Lausanne | Pre-seed | $630K | 2025-12-18 | $947K | Venture Kick, Foundation for Innovation and Technology (FIT) | 1 to 10 | 2019 |
| Cutiss | Cutiss is a life science company that produces regenerative medicine and engineers skin tissue. | Biotech | Zürich | Series C | $38.8M | 2025-09-10 | $94.6M | Innosuisse | 11 to 50 | 2017 |
| Scanvio | Scanvio provides AI-augmented ultrasound software to help diagnose endometriosis faster. | Health care | Zürich | Seed | $3.4M | 2025-07-15 | $3.8M | Venture Kick, InnoBooster, Future of Health Grant | 11 to 50 | 2024 |
| Comphya | Comphya develops an active implantable medical device to restore erectile function in patients who do not respond to oral drugs. | Biotech | Lausanne | Series A | $4.0M | 2025-07-08 | $14.2M | Venture Kick, Verve Ventures, Nest Collective Foundation | 1 to 10 | 2017 |
| GlycoEra | GlycoEra researches and produces extracellular protein degraders for treating autoimmune diseases. | Biotech | Wädenswil | Series B | $130.0M | 2025-05-27 | $179.3M | Sofinnova Partners, Bristol-Myers Squibb, 5AM Ventures +1 | 11 to 50 | 2020 |
| Rhygaze | Rhygaze develops a gene therapy that targets cone cells to restore vision in blinding diseases. | Biotech | Basel | Series A | $86.0M | 2025-01-10 | $97.3M | Google Ventures, F-Prime, ARCH Venture Partners +2 | 11 to 50 | 2024 |
| Noema Pharma | Noema Pharma develops therapies that treat disabling symptoms of brain and nervous system conditions. | Biotech | Basel | Series B | $147.2M | 2024-12-11 | $316.5M | Polaris Partners, Sofinnova Partners, Invus +2 | 11 to 50 | 2019 |
| Lyfegen | Lyfegen provides SaaS rebate management software for the healthcare industry. | Fintech | Basel | Series A | $5.7M | 2024-12-11 | MassChallenge, Innosuisse, APEX Ventures +1 | 51 to 100 | 2018 | |
| Alentis Therapeutics | Alentis Therapeutics develops novel therapeutics for advanced liver disease and cancer. | Biotech | Allschwil | Series D | $181.4M | 2024-11-12 | Bpifrance, HTGF (High-Tech Gruenderfonds), RA Capital Management +2 | 51 to 100 | 2019 | |
| Retinai | RetinAI is a company that simplifies clinic, research, and pharmaceutical workflows to improve healthcare. | Artificial intelligence | Bern | Series B | $7.8M | 2024-10-16 | $16.8M | Venture Kick, Verve Ventures, Matterwave Ventures | 11 to 50 | 2016 |
| Translation-X | Translation-X is a spin-off project developing novel therapeutics for autism spectrum disorders. | Biotech | Basel | Pre-seed | $177K | 2024-09-30 | Venture Kick | 1 to 10 | 2022 | |
| ImmunOs Therapeutics | ImmunOs Therapeutics is a clinical-stage biotechnology company. | Biotech | Schlieren | Series C | $11.0M | 2024-09-17 | Lightspeed Venture Partners, Innosuisse, Mission BioCapital +1 | 11 to 50 | 2014 | |
| CorFlow Therapeutics | CorFlow Therapeutics develops proprietary technologies to diagnose and treat microvascular obstructions. | Biotech | Baar | Series B | $48.5M | 2024-09-10 | $66.1M | Innosuisse, Unorthodox Ventures, Panakes Partners +2 | 11 to 50 | 2016 |
| Vandria | Vandria creates mitophagy inducers that renew cells to address ageing and chronic disorders. | Health care | Lausanne | Series A | $10.1M | 2024-08-21 | Innosuisse, Dolby Family Ventures, Eurostars +1 | 1 to 10 | 2021 | |
| Regenosca | Regenosca develops biomaterials that serve as alternatives to autologous tissue substitutes for soft tissue repair. | Biotech | Lausanne | Pre-seed | $1.1M | 2024-07-22 | $1.4M | MassChallenge, Venture Kick, Foundation for Innovation and Technology (FIT) +1 | 1 to 10 | 2019 |
| Asceneuron | Asceneuron develops therapeutics for orphan tauopathies and Alzheimer's disease. | Biotech | Lausanne | Series C | $100.0M | 2024-07-16 | OrbiMed, Novo Holdings, EQT Life Sciences +1 | 1 to 10 | 2012 | |
| SkyCell | SkyCell develops temperature-controlled logistics containers for the pharmaceutical industry. | Health care | Zürich | Series D | $59.0M | 2024-06-25 | M&G Investments, MVM Life Science Partners, Tybourne Capital Management +1 | 101 to 250 | 2013 | |
| iOnctura | iOnctura is a clinical-stage biotechnology company developing treatments for cancer. | Biotech | Geneva | Series B | $85.7M | 2024-06-20 | European Innovation Council, M Ventures, VI Partners +2 | 11 to 50 | 2017 |
Table 1. Health care startups in Switzerland: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 353.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Windward Bio | Windward Bio develops monoclonal antibodies for advanced immunological diseases. | Biotech | Basel | Series B | $165.0M | 2026-05-04 | $365.0M | Qiming Venture Partners, OrbiMed, Novo Holdings +2 | 11 to 50 | 2024 |
| 2 | Laza Medical | Laza Medical produces AI-powered robotic imaging systems for cardiovascular treatments. | Artificial intelligence | Pfaffikon | Series B | $160.0M | 2026-11-04 | $196.0M | Page One Ventures, Unorthodox Ventures, The Capital Partnership | 1 to 10 | 2020 |
| 3 | Vaderis Therapeutics | Vaderis Therapeutics develops targeted therapies for rare vascular diseases in clinical trials. | Biotech | Basel | Series B | $152.0M | 2026-08-11 | $170.6M | Medicxi | 11 to 50 | 2019 |
| 4 | NovaGo Therapeutics | NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke. | Biotech | Schlieren | Series B | $29.7M | 2026-08-31 | $39.7M | Kinled Holding, Pureos Bioventures | 1 to 10 | 2015 |
| 5 | Leman Biotech | Leman Biotech develops cancer immunotherapies as a biotech company. | Biotech | Lausanne | Series A | $28.8M | 2026-01-26 | $46.8M | Tiantu Capital, Fuho Capital | 11 to 50 | 2021 |
| 6 | Rivia | Rivia provides an operating system that aims to improve clinical trial outcomes. | Artificial intelligence | Zürich | Series A | $15.0M | 2026-03-18 | $18.2M | Speedinvest, Nina Capital, Amino Collective | 1 to 10 | 2022 |
| 7 | ORamaVR | ORamaVR develops extended reality software that speeds up computational medical applications. | Education | Geneva | Seed | $4.5M | 2026-01-27 | $5.9M | European Commission, Innosuisse, FONGIT +1 | 11 to 50 | 2016 |
| 8 | Alithea Genomics | Alithea Genomics develops molecular biology tools and sequencing solutions for large-scale gene expression analysis. | Biotech | Lausanne | Seed | $3.8M | 2026-03-04 | $9.9M | Foundation for Innovation and Technology (FIT), TechU Ventures, Eurostars +1 | 11 to 50 | 2020 |
| 9 | Bewelab SA | Bewelab SA uses neuroscience-based digital interventions to reduce cravings at the neural level. | Health care | Fribourg | Seed | $2.5M | 2026-08-19 | $5.5M | Future of Health Grant, Fribourg Innovation | 1 to 10 | 2021 |
| 10 | Avea Life | Avea Life formulates science-based longevity supplements in Switzerland. | Health care | Zug | Angel | $2.2M | 2026-10-20 | $7.6M | Maximon | 1 to 10 | 2021 |
Table 2. Health care startups in Switzerland: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Venture Kick | Startup incubator | Schlieren, Switzerland | 50 | 14% | 1 | Genknowme |
| 2 | Innosuisse | Government investment office | Berne, Switzerland | 17 | 5% | 1 | ORamaVR |
| 3 | Foundation for Innovation and Technology (FIT) | Entrepreneurship program | Lausanne, Switzerland | 13 | 4% | 3 | Carewell, Alithea Genomics, Genknowme |
| 4 | Verve Ventures | Venture capital firm | Zug, Switzerland | 9 | 3% | ||
| 5 | MassChallenge | Startup accelerator | Boston, United States | 9 | 3% | ||
| 6 | Novartis Venture Fund | Corporate venture arm | Basel, Switzerland | 8 | 2% | ||
| 7 | Novo Holdings | Corporate venture arm | Hellerup, Denmark | 7 | 2% | 1 | Windward Bio |
| 8 | BioMedPartners | Venture capital firm | Basel, Switzerland | 7 | 2% | ||
| 9 | VI Partners | Venture capital firm | Altendorf, Switzerland | 6 | 2% | ||
| 10 | HTGF (High-Tech Gruenderfonds) | Venture capital firm | Bonn, Germany | 5 | 1% | ||
| 11 | SICTIC | Angel group | Zürich, Switzerland | 5 | 1% | ||
| 12 | Versant Ventures | Venture capital firm | Menlo Park, United States | 5 | 1% | ||
| 13 | OrbiMed | Private equity firm | New York, United States | 4 | 1% | 1 | Windward Bio |
| 14 | Sofinnova Partners | Venture capital firm | Paris, France | 4 | 1% | ||
| 15 | EQT Life Sciences | Private equity firm | Amsterdam, The Netherlands | 4 | 1% |
Table 3. Health care startups in Switzerland: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Biotech | 171 | 48% | $3.9B |
| Software | 73 | 21% | $474.2M |
| Artificial intelligence | 33 | 9% | $382.1M |
| Hardware | 25 | 7% | $143.9M |
| Commerce | 10 | 3% | $17.4M |
| Education | 7 | 2% | $15.9M |
| Fintech | 4 | 1% | |
| Cybersecurity | 1 | 0% | $4.7M |
| Energy | 1 | 0% |
Table 4. Health care startups in Switzerland by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Health care startups in Switzerland by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 6. Health care startups in Switzerland by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 2 | 5% | $160.2M |
| October 2026 | 4 | 9% | $141.8M |
| September 2026 | 3 | 7% | $10.8M |
| August 2026 | 4 | 9% | $186.1M |
| July 2026 | 3 | 7% | $39.9M |
| June 2026 | 4 | 9% | $105.4M |
| May 2026 | 5 | 11% | $212.6M |
| April 2026 | 1 | 2% | |
| March 2026 | 5 | 11% | $29.8M |
| February 2026 | 4 | 9% | $1.7M |
| January 2026 | 5 | 11% | $268.4M |
| December 2025 | 3 | 7% | $7.8M |
| November 2025 | 1 | 2% | $188K |
Table 7. Health care startups in Switzerland: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 40 | 11% | $1.2B |
| 2025 | 43 | 12% | $531.2M |
| 2024 | 46 | 13% | $1.1B |
| 2023 | 34 | 10% | $258.3M |
| 2022 | 30 | 8% | $236.4M |
| 2021 | 36 | 10% | $270.1M |
Table 8. Health care startups in Switzerland by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 39 | 11% |
| 2020 to 2022 | 68 | 19% |
| 2015 to 2019 | 126 | 36% |
| 2010 to 2014 | 66 | 19% |
| Before 2010 | 51 | 15% |
Table 9. Health care startups in Switzerland by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 175 | 50% |
| 11 to 50 | 129 | 37% |
| 51 to 100 | 29 | 8% |
| 101 to 250 | 10 | 3% |
| 251 to 500 | 1 | 0% |
| 1,001 to 5,000 | 2 | 1% |
| 10,001 or more | 1 | 0% |
Table 10. Health care startups in Switzerland by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its headquarters is in Switzerland. On 16 November 2026 that is 353 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 30 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 353 rows: 67 have no round amount, 0 no city and 111 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in Switzerland are on the list?
- 353, in the file dated 16 November 2026. 44 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 353 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.